Incidence of mucositis in patients with head and neck squamous cell carcinoma treated with radiotherapy plus cetuximab: a pilot study

By Bodard Anne-Gaëlle   Hrifach Abdelbaste   Salino Samuel   Fabris Matthieu   Desoutter Aline   Pommier Pascal   Fayette Jérôme  

Médecine Buccale - Chirurgie Buccale, Vol. 18, Iss. 3, 2012-09 ,pp. : 181-185

Edp Sciences

Access to resources Recommend Favorite

Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck

By Levy Adrian R.   Johnston Karissa M.   Sambrook Jennifer   Donato Bonnie   Penrod John R.   Corral Mitra   Chasen Martin  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2253-2259

Informa Healthcare

Access to resources Recommend Favorite

PI3K/PTEN/AKT/mTOR polymorphisms: Association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab‐docetaxel

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 4, 2015-04 ,pp. : 471-478

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey

By  

Oncology, Vol. 93, Iss. 1, 2017-04 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

Cisplatin versus Cetuximab Given Concurrently with Definitive Radiation Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

By  

Oncology, Vol. 85, Iss. 5, 2013-11 ,pp. : 290-296

Karger

Access to resources Recommend Favorite